Anna Niklasson
Impact in
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Gastroenterology top 5%
- Gastroesophageal reflux and treatments
Papers in
-
- Gastroesophageal reflux and treatments 6
- Surgery 3
- Helicobacter pylori-related gastroenterology studies 2
- Co-authors
- Einar S. Björnsson (6 shared papers)Naga Chalasani (2 shared papers)Craig Lammert (2 shared papers)Stefán Einarsson (1 shared paper)Chandan Saha (1 shared paper)Magnus Simrén (4 shared papers)Lina Lindström (2 shared papers)Greger Lindberg (2 shared papers)
- Journals
- Gastroenterology (3 papers)Patient (2 papers)Hepatology (2 papers)Cardiovascular Drugs and Therapy (1 paper)Acta Paediatrica (1 paper)
- Partner nations
- SwedenUnited StatesAustralia
In The Last Decade
Anna Niklasson
21 papers receiving 833 citations
Peers
Comparison fields: 5 of 84
- Pharmacology 429
- Gastroenterology 134
- Hepatology 64
- Clinical Biochemistry 49
- Oncology 153
Countries citing papers authored by Anna Niklasson
This map shows the geographic impact of Anna Niklasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Niklasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Niklasson more than expected).
Fields of papers citing papers by Anna Niklasson
This network shows the impact of papers produced by Anna Niklasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Niklasson. The network helps show where Anna Niklasson may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Niklasson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 318 | |
| 2 | 2009 | 209 | |
| 3 | 2010 | 121 | |
| 4 | 1985 | 36 | |
| 5 | 1990 | 31 | |
| 6 | 2003 | 30 | |
| 7 | 2008 | 25 | |
| 8 | 2022 | 19 | |
| 9 | 2017 | 17 | |
| 10 | 2020 | 16 | |
| 11 | 1990 | 15 | |
| 12 | 2011 | 12 | |
| 13 | 2014 | 8 | |
| 14 | 2014 | 5 | |
| 15 | 2019 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2013 | 3 | |
| 18 | 2008 | 3 | |
| 19 | 2012 | 2 | |
| 20 | 1993 | 2 |
About Anna Niklasson
Anna Niklasson is a scholar working on Gastroenterology, Surgery, Pharmacology, Nephrology and Cardiology and Cardiovascular Medicine, having authored 22 papers that have together received 883 indexed citations. Recurring topics across this work include Gastroesophageal reflux and treatments (6 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Metabolism and Genetic Disorders (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Diet and metabolism studies (1 paper), Cardiac, Anesthesia and Surgical Outcomes (1 paper) and Ion Transport and Channel Regulation (1 paper). The work is most often cited by research in Pharmacology (429 citations), Gastroenterology (134 citations), Hepatology (64 citations), Clinical Biochemistry (49 citations) and Oncology (153 citations). Anna Niklasson has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include Einar S. Björnsson, Naga Chalasani, Craig Lammert, Stefán Einarsson, Chandan Saha, Magnus Simrén, Lina Lindström, Greger Lindberg, Anna Rydén and G. Cederblad. Their work appears in journals such as Gastroenterology, Patient, Hepatology, Cardiovascular Drugs and Therapy and Acta Paediatrica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.